BIOMAT Database Logo BIOMAT Database Logo

[Pyrimidine derivatives increase antibiotic therapy efficacy after ionizing irradiation]. 1998

A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Institute of Organic Chemistry, Ufa Scientific Centre, Russian Academy of Sciences, Bashkir State Medical University.

Pyrimidine derivatives increased the antibiotic therapy efficacy in albino rats irradiated with RUM-7 apparatus for close-focus roentgenotherapy. 2-Methyl-4-amino-6-oxypyrimidine was twice as efficient as oxymethyluracil and 6 times as efficient as methyluracil in the stimulation of the skin reparative regeneration. When the total irradiation was performed with LUCH-1 apparatus in a dose of 6 Gy the pyrimidine derivatives also increased the antibiotic therapy efficacy. After the prophylactic use of the pyrimidine derivatives for 7 days prior to the total irradiation their therapeutic effect increased, the level of the exudative component lowered, the tissue epithelization increased, the terms of the wound healing decreased and the animal lifespan increased.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Ultraviolet irradiation of pyrimidine derivatives.
September 1955, Science (New York, N.Y.),
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Bone Marrow Mesenchymal Stem Cells Increase Survival after Ionizing Irradiation Combined with Wound Trauma: Characterization and Therapy.
January 2014, Journal of cell science & therapy,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
[Increase in efficacy of antibiotic therapy of anthrax under experimental conditions].
January 2002, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
[Effect of prodigiozan and pyrimidine derivatives on the effectiveness of the antibiotic therapy of experimental infections].
September 1979, Antibiotiki,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
[Structural anomalies of dog hemoglobin after ionizing irradiation].
January 1981, Ukrainskii biokhimicheskii zhurnal (1978),
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Thyroid cancer after external or internal ionizing irradiation.
January 2009, Hellenic journal of nuclear medicine,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
p53 deficiency augments nucleolar instability after ionizing irradiation.
December 2019, Oncology reports,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors.
January 2023, Molecules (Basel, Switzerland),
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
[Evaluation of pregnancies after ionizing irradiation of the gonads].
October 1962, Strahlentherapie,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and F P Savitskiĭ, and Z F Ismagilova, and Iu G Tropynina, and V A Davydova, and T A Sapozhnikova
Carcinogenesis after sublethal ionizing irradiation and regular avoidance irritation.
January 1982, Neoplasma,
Copied contents to your clipboard!